Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV 16 Infection”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Post-approval studies (Phase 4)UnknownNCT05415345
What this trial is testing

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection
Xiamen Innovax Biotech Co., Ltd 480
Not applicableUnknownNCT05587725
What this trial is testing

Human Papillomavirus in Young People Epidemiological Research 3

Who this might be right for
Human Papillomavirus InfectionHPVHPV Infection+4 more
Monash University 200
Not applicableUnknownNCT04969445
What this trial is testing

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 647
Large-scale testing (Phase 3)Study completedNCT00092521
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 5,759
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Large-scale testing (Phase 3)UnknownNCT05580341
What this trial is testing

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Who this might be right for
Cervical CancerGenital WartCIN+2 more
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Early research (Phase 1)Ended earlyNCT01493154
What this trial is testing

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Not applicableActive Not RecruitingNCT03309033
What this trial is testing

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Malignant Neoplasm
National Cancer Institute (NCI) 991
Large-scale testing (Phase 3)Study completedNCT04635423
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of the 9vHPV Vaccine in Japanese Males (V503-064)

Who this might be right for
Warts, GenitalNeoplasms, Anal
Merck Sharp & Dohme LLC 1,059
Large-scale testing (Phase 3)Study completedNCT02576054
What this trial is testing

Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 101
Not applicableUnknownNCT01427777
What this trial is testing

3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China

Who this might be right for
Anogenital Human Papilloma Virus Infection
Guangxi Center for Disease Control and Prevention 300
Large-scale testing (Phase 3)Study completedNCT01381575
What this trial is testing

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,447
Large-scale testing (Phase 3)Study completedNCT00092547
What this trial is testing

Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Who this might be right for
HumanPapillomavirus Infections
Merck Sharp & Dohme LLC 1,781
Testing effectiveness (Phase 2)Study completedNCT00693615
What this trial is testing

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 60
Not applicableUnknownNCT04704908
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 979
Not applicableUnknownNCT04297670
What this trial is testing

HPV Prevalence in 16-20 Year Old Males

Who this might be right for
HPV Infection
Laval University 681
Large-scale testing (Phase 3)Study completedNCT01651949
What this trial is testing

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Who this might be right for
Genital WartsAnal CancerAnal Intraepithelial Neoplasia
Merck Sharp & Dohme LLC 2,520
Large-scale testing (Phase 3)Study completedNCT00543543
What this trial is testing

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 14,840
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Large-scale testing (Phase 3)Study completedNCT00943722
What this trial is testing

V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+3 more
Merck Sharp & Dohme LLC 3,074
Load More Results